Back to company

Biotech Force Danmark ApS: Financial statements 2022

CVR: 36434309

Biotech Force Danmark ApS (CVR 36434309) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -2,965,170 and a net result of DKK -2,696,244 compared with DKK -2,265,511 the year before. Equity amounted to DKK -321,320.

Gross Profit
-2,965,170 kr.
Profit/Loss
-2,696,244 kr.
Equity
-321,320 kr.
Total Assets
17,023,483 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--3 mio.-2.7 mio.-321 t.-
2021--1.9 mio.-2.3 mio.2.4 mio.-
2020--1.5 mio.-1.9 mio.4.6 mio.-
2019--485 t.-971 t.5.6 mio.-
2018-3.6 mio.1.2 mio.6.5 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Biotech Force Danmark ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Biotech Force Danmark ApS: The 2021 annual report is outJul 13, 2022

Biotech Force Danmark ApS has published its annual report for 2021. Gross profit came to DKK -1,879,450, and the net result was DKK -2,265,511.

About Biotech Force Danmark ApS

Biotech Force Danmark ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2014. The company is registered under the industry Engroshandel med rengøringsmidler. The company was previously named ANTi-COVID 19 Danmark ApS and GL. DONSVEJ 6 KOLDING ApS. The management consists of Jette Kjærgaard. The company's owners include JMR HOLDING, KOLDING A/S, PLAN Invest A/S and Reinert Family Invest ApS. In 2025, the company reported a gross profit of DKK -3,515,065 and a net result of DKK -4,321,793 compared with DKK -2,161,531 the year before. Equity amounted to DKK -18,527,805.